Friedman Bart bought OVID
April 7, 2026 · Form 4 insider transaction
Friedman Bart bought 8,789 shares of Ovid Therapeutics Inc. at $2.56 per share, a transaction worth $22.5K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,789
Price
$2.56
Total value
$22.5K
InsiderFriedman Bart
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateApril 7, 2026
Filing dateApril 9, 2026
Shares owned after8,789
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a restricted stock unit ("RSU") award issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of 50% of an annual cash retainer for service on the Issuer's Board of Directors in the aggregate amount of $22,500. The RSUs vest 25% upon grant and 25% on each of June 30, 2026, September 30, 2026 and December 31, 2026, subject to the Reporting Person's continuous service through each such vesting date.